SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company Nov 04, 2022 17:47 HKT/SGT Read More
エーザイ、タイにおいてThai Life Insuranceとアルツハイマー病をはじめとする認知症の治療に対するアクセス支援に向けた協働について合意 Nov 04, 2022 16:00 JST Read More
Eisai's Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer's Disease, in Thailand Nov 04, 2022 14:42 HKT/SGT Read More
Eisai Satisfies All-case Study Requirement for Antiepileptic Agent Inovelon Nov 02, 2022 17:34 HKT/SGT Read More
Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination Nov 02, 2022 09:43 HKT/SGT Read More
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round Nov 01, 2022 18:05 HKT/SGT Read More
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round Nov 01, 2022 17:51 HKT/SGT Read More
Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub Oct 31, 2022 19:00 HKT/SGT Read More
エーザイ、「アリセプト(R)」について日本のレビー小体型認知症に係る適応に関する再審査結果に伴う用法・用量の一部変更申請の予定について発表 Oct 31, 2022 17:00 JST Read More
Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children Oct 28, 2022 09:45 HKT/SGT Read More
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE Oct 26, 2022 19:00 HKT/SGT Read More